31 studies found for:    " August 06, 2008":" September 05, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" August 06, 2008":" September 05, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (31 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Attitudes and Beliefs and the Steps of HIV Care
Condition: Human Immunodeficiency Virus Infections
Intervention: Behavioral: Questionnaire
2 Completed Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 10 mg oral solution;   Drug: GSK1265744 5 mg tablet
3 Completed IMARA, Adapting SiHLE for Detained African American Adolescent Females
Condition: HIV Infections
Intervention: Behavioral: IMARA HIV Prevention Intervention
4 Completed An Affect Management Intervention for Juvenile Offenders
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
5 Completed Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Conditions: Cholera;   Vibrio Infections;   Diarrhea
Interventions: Biological: CholeraGarde®;   Biological: Placebo
6 Completed
Has Results
Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS
Conditions: HIV Infections;   Fatigue
Interventions: Drug: Armodafinil;   Drug: Placebo
7 Completed
Has Results
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
Condition: HIV Infections
Intervention: Drug: Raltegravir
8 Completed
Has Results
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Condition: HIV Infection
Interventions: Drug: Placebo;   Drug: Maraviroc
9 Completed Affect Management Intervention for Early Adolescents Wtih Mental Health Problems
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
10 Unknown  Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir and Abacavir/Lamivudine
11 Completed Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo
12 Completed Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
Condition: HIV Infections
Intervention:
13 Completed
Has Results
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
Conditions: HIV Infections;   HSV-2 Genital Herpes
Intervention: Drug: 3% SPL7013 Gel (VivaGel)
14 Completed Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
Condition: HIV Infections
Intervention:
15 Completed Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
Condition: Acute HIV Infection
Interventions: Drug: Raltegravir, tenofovir, emtricitibine;   Drug: Efavirenz plus tenofovir with emtricitibine
16 Terminated TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA.
Condition: HIV-1
Intervention: Drug: TMC278
17 Active, not recruiting Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
Conditions: HIV;   Hepatitis C;   Infections
Intervention: Drug: Pegylated interferon alfa and ribavirin (PEG-IFN/RBV)
18 Terminated
Has Results
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
Conditions: HIV;   Hepatitis C;   Liver Disease;   Fatty Liver;   Steatosis
Intervention: Drug: Pioglitazone
19 Completed TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
Conditions: HIV;   AIDS;   Fungal Infection
Intervention: Drug: TMC125
20 Completed TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Conditions: HIV;   AIDS;   Hepatic Impairment
Intervention: Drug: TMC278

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years